These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14688491)

  • 1. Plasma renin measurement in the management of hypertension: the V and R hypothesis.
    Moser M; Izzo JL
    J Clin Hypertens (Greenwich); 2003; 5(6):373-6. PubMed ID: 14688491
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against.
    Weinberger MH
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):36-7; quiz 38-9. PubMed ID: 15655386
    [No Abstract]   [Full Text] [Related]  

  • 3. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin and prorenin as biomarkers in hypertension.
    Jan Danser AH
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):508-14. PubMed ID: 22820372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 7. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ; Laragh JH; Atlas SA; Case DB
    J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
    Sezai A; Osaka S; Yaoita H; Arimoto M; Hata H; Shiono M; Sakino H
    Ann Thorac Cardiovasc Surg; 2016 Jun; 22(3):161-7. PubMed ID: 27086671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
    Smith RD; Yokoyama H; Averill DB; Cooke L; Brosnihan KB; Schiffrin EL; Ferrario CM
    Am J Cardiovasc Drugs; 2006; 6(5):335-42. PubMed ID: 17083268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular remodeling in hypertension: mechanisms and treatment.
    Schiffrin EL
    Hypertension; 2012 Feb; 59(2):367-74. PubMed ID: 22203749
    [No Abstract]   [Full Text] [Related]  

  • 13. [The characteristics of the renin-angiotensin system, the central hemodynamics and the vascular reactivity in healthy subjects with a low plasma renin activity].
    Pikovskaia NB; Shterental' ISh
    Fiziol Cheloveka; 1990; 16(3):50-5. PubMed ID: 2210144
    [No Abstract]   [Full Text] [Related]  

  • 14. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Jun; 14(6 Pt 1):491-503. PubMed ID: 11411727
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
    Laragh JH; Sealey JE
    Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between blood insulin concentration, renin-angiotensin-aldosterone system and clinical picture of hypertension].
    Didenko VA; Simonov DV
    Ter Arkh; 1999; 71(1):26-31. PubMed ID: 10097296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hypertension in patients with type 2 diabetes mellitus].
    Hess K
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2489-92. PubMed ID: 23114910
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
    van Paassen P; Navis GJ; De Jong PE; De Zeeuw D
    Eur J Clin Invest; 1999 Dec; 29(12):1019-26. PubMed ID: 10583449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
    Egan BM; Basile JN; Rehman SU; Davis PB; Grob CH; Riehle JF; Walters CA; Lackland DT; Merali C; Sealey JE; Laragh JH
    Am J Hypertens; 2009 Jul; 22(7):792-801. PubMed ID: 19373213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system blockade: to what extent?
    Ménard J; Azizi M
    J Hypertens; 2004 Mar; 22(3):459-62. PubMed ID: 15076148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.